Puma Biotech (PBYI) Tops Q1 EPS by 89c

Puma Biotech (NASDAQ: PBYI) reported Q1 EPS of $0.21, $0.89 better than the analyst estimate of ($0.68). Revenue for the quarter came in at $99.1 million versus the consensus estimate of $67.25 million.

For earnings history and earnings-related data on Puma Biotech (PBYI) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Morgan Stanley upgrades CDW on stronger AI-driven server demand
• Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance